President Trump Nominates Conservative Physician, Scott Gottlieb, To Head the FDA
President Donald Trump has nominated Dr. Scott Gottlieb as potential had of the US Food and Drug Administration (FDA) agency. Gottlieb is regarded as a conservative physician and businessman with extensive experience of how the pharmaceutical industry is run. In fact, many voices in the health industry call for the US Senate to approve his nomination for the job.
Dr. Gottlieb was known to always criticize the Obamacare plan and argue drug pricing issues among approval matters for new drugs. It is considered that with his hands on the FDA wheel, he will relax government regulations for approving food, drugs, cosmetics, dietary supplements and tobacco among others. Pharmaceutical companies and other players within the health industry view his nomination as a good sign for the industry.
Industry executives say Gottlieb is knowledgeable, experienced and balanced
"We view this as a favorable development for the sector," said Brian Skorney, an analyst with Robert W. Baird, adding that "Thank God it's Gottlieb." A survey of 53 pharmaceutical executives revealed that 72% of them preferred having Gottlieb as the head of the FDA over other candidates. Players in the industry say he is "a pragmatic leader with an eye toward both expedited approvals and safety.
Several players within the industry credit Gottlieb with being knowledgeable, experienced and balanced, the Huffington Post wrote. Another top contender for the FDA position is Jim O'Neill, but his past claims that drugs should be approved and then afterward proven effective is working against him. O'Neill is, however, a good friend of Peter Thiel, co-founder of PayPal and presidential advisor on technology and science.
Who is Scott Gottlieb?
Dr. Gottlieb is now 44 years old and a former deputy commissioner at the FDA. He is a resident fellow at the American Enterprise Institute and a member of the boards of several drug companies. He is also a partner with a big venture capital fund and a visible advocate for pharmaceutical companies and the health business.
Gottlieb equally contributes opinion pieces to Forbes and the Wall Street Journal. A survivor of lymphoma, he advocates that new drugs are approved quickly and new uses are also approved in time for existing drugs. According to Dr. Michael Carome of the Public Citizen's Health Research Group, Gottlieb is the ideal choice for FDA because he "has spent most of his career dedicated to promoting the financial interests of the pharmaceutical industry."
Nasal Irrigation Pots Increase Risk For Brain-Eating Amoebas
The FDA have issued a health warning to those who use nasal irrigation pots, or Neti pots, to make sure that they use distilled water, or even boil the water first, to avoid infections. The warning came after some reports of brain-eating amoeba surfaced not long ago during the flu season.
FDA Approves Emflaza as Drug for Treating Muscular Dystrophy
The US Food and Drug Administration (FDA) has approved the use of deflazacort, marketed under the brand name Emflaza, for the treatment of Duchenne muscular dystrophy (DMD) in children. The steroid drug is manufactured by Marathon Pharmaceuticals and is the first to be so approved by the FDA to treat people with the condition in the United States.
Multiple Sclerosis Drug Can Cause Severe Liver Injuries, New Study Suggests
As the FDA starts to approve certain drugs, what’s the truth behind claims that MS drugs could potentially cause severe liver injuries? Is this the downside of Multiple Sclerosis drugs that we cannot truly evade? Here’s what health experts have to say.
FDA On Hyland's Teething Products With Poisonous Belladonna: Throw Them Out!
The FDA has found inconsistent amount of belladona in Hyland's teething products - some exceeding what's claimed on the label. Ever since the warning was first issued in 2010, the agency has been getting reports from parents sharing the adverse effects the products had on their children.
FDA Finally Set To Approve Multiple Sclerosis Drug This March, Is There A Catch?
As the number of clinical trials are rising up, the hope for the discovery of the cure to Multiple Sclerosis is also believed to be at hand. But why do a lot of scientists claim this approval of FDA as the 'medical breakthrough' for the auto-immune disease? Is this the cure we've long been waiting for? Here are the details.
She Campaigned Against The Medical Device That Caused Her Cancer; Woman From Pittsburgh Dies At 57
A woman from Pittsburgh was diagnosed with cancer following surgery using a power morcellator. She then spent her life raising awareness on the dangers of the said device— before she died from the disease at the age of 57.
MORE IN ITECHPOST
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.